Revelation Biosciences logo

Revelation Biosciences

REVB | NASDAQ
Chart Builder DCF Calculator
$3.82
-$0.44 (-10.43%)
At close: Nov 16, 2026, 4:00 PM ET
$3.75
-$0.07 (-1.83%)
After-hours: Nov 16, 2026, 7:30 PM ET
-10.43%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
29.7
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #812/1021 (Top 80%)

Key Statistics

Market Data

Market Cap $2.17M
1D Range
3.71 4.00
52W Range
3.29 32.20

Valuation (TTM)

PE -0.09
PB 0.30
EV/EBITDA 0.50

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting th...

Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Nov 17, 2020
Fiscal Year January - December

Latest News

Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026

1 month ago · gurufocus.com

Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study

3 months ago · businesswire.com

Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.